Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Health Economics and Outcomes Research (HEOR) Market: By Drugs: Developing Drugs, Approved Drugs; By Service: Real World Evidence, Payer Evidence, Others; By Offering; By End Use; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Health Economics and Outcomes Research (HEOR) Market Outlook
The global health economics and outcomes research (HEOR) industry attained a value of USD 1.23 billion in 2020. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 12.5% to reach USD 2.46 billion by 2026.
-market.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America to be among the Leading Regions for Health Economics and Outcome Research (HEOR) Market
North America region has been laying emphasis on the value-based care and excellent results in pharmaceutical research. The United States has active presence of many key players which are involved in drug research and favourable government regulations for HEOR services. These factors have helped North America to emerge as one of the largest regional market for HEOR. Europe is also likely to have substantial growth owing to the higher usage of advanced drugs and treatment methods. The regulations that are supporting the accessibility of the health services in Europe have also helped HEOR services.
Health Economics and Outcomes Research (HEOR): Market Segmentation
Health economics and outcomes research (HEOR) refer to the services utilised by healthcare and pharma businesses in order to find the value, cost and cost-effectiveness of the products or techniques. The healthcare and pharmaceutical companies are able to make more informed strategic decisions for their products with the help of observational data, price comparison and other market indicators.
-market-by-service.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on drugs, the HEOR industry is divided into:
- Developing Drugs
- Approved Drugs
On the grounds of service, market is segmented into:
- Real World Evidence
- Payer Evidence
- Pricing and Reimbursement
- Epidemiology Studies
- Market Access
- Others
The market is divided on the basis of offering into:
- Outsourced
- In-house
The industry finds its end use in the following:
- Healthcare Providers
- Government Organizations
- Pharma and Biotech Companies
- Healthcare Payers
The regional markets for health economics and outcomes research (HEOR) industry can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
-market-by-region.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Drug Development and Clinical Trials to Bolster the Health Economics and Outcomes Research (HEOR) Market
The pharmaceutical industry is witnessing rapid growth in the recent years. The increasing drug development is driving the demand for HEOR industry. With development of new drugs in the pharmaceutical industry, there has been a surge in the number of clinical trials required. Health economics and outcomes research help the clinical development by providing valuable information regarding specific drugs such as accessibility to the population and comparative pricing of rival drugs. The price for a new drug developed and revision of prices of existing drugs is done with the aid of HEOR services which is providing impetus to the growth of industry.
Key Industry Players in the Health Economics and Outcomes Research (HEOR) Market
The report gives a detailed analysis of the following key players in the health economics and outcomes research (HEOR) market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- IQVIA Inc.
- Medpace, Inc.
- Certara, Inc.
- Syneos Health
- McKesson Corporation
- Optum, Inc
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Drugs, Service, Offering, End Use, Region |
| Breakup by Drugs | Developing Drugs, Approved Drugs |
| Breakup by Service | Real World Evidence, Payer Evidence, Pricing and Reimbursement, Epidemiology Studies, Market Access, Others |
| Breakup by Offering | Outsourced, In-house |
| Breakup by End Use | Healthcare Providers, Government Organizations, Pharma and Biotech Companies, Healthcare Payers, Others |
| Breakup by Region | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | IQVIA Inc., Medpace, Inc., Certara, Inc., Syneos Health, McKesson Corporation, Optum, Inc, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Health Economics and Outcomes Research (HEOR) Market Analysis
8.1 Key Industry Highlights
8.2 Global Health Economics and Outcomes Research (HEOR) Historical Market (2017-2021)
8.3 Global Health Economics and Outcomes Research (HEOR) Market Forecast (2022-2027)
8.4 Global Health Economics and Outcomes Research (HEOR) Market by Drugs
8.4.1 Developing Drugs
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Approved Drugs
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.5 Global Health Economics and Outcomes Research (HEOR) Market by Service
8.5.1 Real World Evidence
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Payer Evidence
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Pricing and Reimbursement
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2017-2021)
8.5.3.3 Forecast Trend (2022-2027)
8.5.4 Epidemiology Studies
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2017-2021)
8.5.4.3 Forecast Trend (2022-2027)
8.5.5 Market Access
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2017-2021)
8.5.5.3 Forecast Trend (2022-2027)
8.5.6 Others
8.6 Global Health Economics and Outcomes Research (HEOR) Market by Offering
8.6.1 Outsourced
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 In-house
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.7 Global Health Economics and Outcomes Research (HEOR) Market by End Use
8.7.1 Healthcare Providers
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2017-2021)
8.7.1.3 Forecast Trend (2022-2027)
8.7.2 Government Organizations
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2017-2021)
8.7.2.3 Forecast Trend (2022-2027)
8.7.3 Pharma and Biotech Companies
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2017-2021)
8.7.3.3 Forecast Trend (2022-2027)
8.7.4 Healthcare Payers
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2017-2021)
8.7.4.3 Forecast Trend (2022-2027)
8.8 Global Health Economics and Outcomes Research (HEOR) Market by Region
8.8.1 Market Share
8.8.1.1 North America
8.8.1.2 Europe
8.8.1.3 Asia Pacific
8.8.1.4 Latin America
8.8.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Cost Analysis
13 Procurement Strategy
13.1 Sourcing Model
13.2 Engagement Model
13.3 Pricing Model
14 Billing Rates
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 IQVIA Inc.
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Medpace, Inc.
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Certara, Inc.
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Syneos Health
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 McKesson Corporation
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Optum, Inc
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Others
16 Industry Events and Developments
List of Key Figures and Tables
1. Global Health Economics and Outcomes Research (HEOR) Market: Key Industry Highlights, 2016 and 2026
2. Global Health Economics and Outcomes Research (HEOR) Historical Market: Breakup by Drug (USD Billion), 2017-2021
3. Global Health Economics and Outcomes Research (HEOR) Market Forecast: Breakup by Drug (USD Billion), 2022-2027
4. Global Health Economics and Outcomes Research (HEOR) Historical Market: Breakup by Services (USD Billion), 2017-2021
5. Global Health Economics and Outcomes Research (HEOR) Market Forecast: Breakup by Services (USD Billion), 2022-2027
6. Global Health Economics and Outcomes Research (HEOR) Historical Market: Breakup by Offering (USD Billion), 2017-2021
7. Global Health Economics and Outcomes Research (HEOR) Market Forecast: Breakup by Offering (USD Billion), 2022-2027
8. Global Health Economics and Outcomes Research (HEOR) Historical Market: Breakup by End Use (USD Billion), 2017-2021
9. Global Health Economics and Outcomes Research (HEOR) Market Forecast: Breakup by End Use (USD Billion), 2022-2027
10. Global Health Economics and Outcomes Research (HEOR) Historical Market: Breakup by Region (USD Billion), 2017-2021
11. Global Health Economics and Outcomes Research (HEOR) Market Forecast: Breakup by Region (USD Billion), 2022-2027
12. North America Health Economics and Outcomes Research (HEOR) Historical Market: Breakup by Country (USD Billion), 2017-2021
13. North America Health Economics and Outcomes Research (HEOR) Market Forecast: Breakup by Country (USD Billion), 2022-2027
14. Europe Health Economics and Outcomes Research (HEOR) Historical Market: Breakup by Country (USD Billion), 2017-2021
15. Europe Health Economics and Outcomes Research (HEOR) Market Forecast: Breakup by Country (USD Billion), 2022-2027
16. Asia Pacific Health Economics and Outcomes Research (HEOR) Historical Market: Breakup by Country (USD Billion), 2017-2021
17. Asia Pacific Health Economics and Outcomes Research (HEOR) Market Forecast: Breakup by Country (USD Billion), 2022-2027
18. Latin America Health Economics and Outcomes Research (HEOR) Historical Market: Breakup by Country (USD Billion), 2017-2021
19. Latin America Health Economics and Outcomes Research (HEOR) Market Forecast: Breakup by Country (USD Billion), 2022-2027
20. Middle East and Africa Health Economics and Outcomes Research (HEOR) Historical Market: Breakup by Country (USD Billion), 2017-2021
21. Middle East and Africa Health Economics and Outcomes Research (HEOR) Market Forecast: Breakup by Country (USD Billion), 2022-2027
22. Global Health Economics and Outcomes Research (HEOR) Market Structure
Key Questions Answered in the Report
In 2020, the global health economics and outcomes research (HEOR) market attained a value of nearly USD 1.23 billion.
The market is projected to grow at a CAGR of 12.5% between 2021 and 2026.
The market is estimated to witness healthy growth in the forecast period of 2022-2027 to reach USD 2.46 billion by 2026.
The major drivers of the market include increasing drug development.
What are the key industry trends of the global health economics and outcomes research (HEOR) market?
The health economics and outcomes research (HEOR) market is being aided by rising awareness about health disorders and the growing population.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Developing and branded drugs are the leading components in the industry.
Real-world evidence, payer evidence, pricing and reimbursement, epidemiology studies, and market access, among others are the leading grounds of service in the industry.
Outsourced and in-house are the leading offerings in the industry.
Healthcare providers, government organisations, pharma and biotech companies, and healthcare payers, among others are the leading end uses in the industry.
The major players in the industry are IQVIA Inc., Medpace, Inc., Certara, Inc., Syneos Health, McKesson Corporation, and Optum, Inc among others.
Analyst Review
The global health economics and outcomes research (HEOR) market attained a value of USD 1.3 billion in 2020, driven by increasing drug development. The market is expected to witness further growth in the forecast period of 2022-2027, growing at a CAGR of 13%. The market is projected to reach USD 2.75 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its drugs, the health economics and outcomes research (HEOR) industry can be segmented into developing and branded drugs. Based on its ground of services, the health economics and outcomes research (HEOR) industry can be segmented into real-world evidence, payer evidence, pricing and reimbursement, epidemiology studies, and market access, among others. Based on its offerings, the health economics and outcomes research (HEOR) industry can be segmented into outsourced and in-house. On the basis of end uses, the market is divided into healthcare providers, government organisations, pharma and biotech companies, and healthcare payers, among others. The major regional markets for health economics and outcomes research (HEOR) are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include IQVIA Inc., Medpace, Inc., Certara, Inc., Syneos Health, McKesson Corporation, and Optum, Inc, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global condylar plate fixation system market is expected to grow at a CAGR of 5.3% during the period 2022-2027. North America, Europe and Asia Pacific are expected to be key markets.
The global c-arms market attained a value of nearly USD 1.85 billion in 2021, driven by the increasing demand for mini c-arms. Aided by the growing demand for minimal invasive procedures, the market i...
The global asthma spacers market was driven by the high prevalence of asthma in the historical period. Aided by rising health care expenditure and a rise in the number of production facilities, the ma...
The global healthcare and medical cleanroom technology market attained a value of USD 1.5 billion in 2021, driven by the rising investments by the governments to improve the hygiene and safety standar...
The global pharmaceutical cleanroom technology market attained a value of USD 7.21 billion in 2021, driven by the growing demand for improved cleanliness and safety standards in the healthcare industr...
NEWSLETTER